Profile data is unavailable for this security.
About the company
Brii Biosciences Ltd is a biotechnology company based in China and the United States principally engaged in developing therapies for infectious diseases. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens. The Company is also developing therapies for COVID-19 and other diseases.
- Revenue in HKD (TTM)665.32k
- Net income in HKD-188.52m
- Incorporated2017
- Employees128.00
- LocationBrii Biosciences Ltd3rd Floor, Building 7Zhongguancun Dongsheng, InternationalNo. 1 North Yongtaizhuang Road, HaidianBEIJING 100192ChinaCHN
- Websitehttps://www.briibio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lee's Pharmaceutical Holdings Ltd | 1.05bn | 16.70m | 683.05m | 1.06k | 40.90 | 0.335 | 4.38 | 0.6487 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | 996,247.90 | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.90 | 0.0943 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
Antengene Corporation Ltd | 72.58m | -626.70m | 688.39m | 201.00 | -- | 0.5564 | -- | 9.49 | -1.02 | -1.02 | 0.118 | 1.83 | 0.0358 | 0.9773 | 3.41 | 361,074.00 | -30.91 | -53.57 | -36.46 | -58.94 | 81.74 | -- | -863.51 | -1,987.01 | 6.43 | -- | 0.1491 | -- | -57.97 | -- | 3.38 | -- | -- | -- |
Sirnaomics Ltd | 0.00 | -614.14m | 712.50m | 145.00 | -- | 2.27 | -- | -- | -8.08 | -8.08 | 0.00 | 3.58 | 0.00 | -- | -- | 0.00 | -70.91 | -- | -71.22 | -- | -- | -- | -- | -- | -- | -- | 0.6176 | -- | -- | -- | 10.88 | -- | -- | -- |
Genor Biopharma Holdings Ltd | 0.00 | -727.17m | 748.49m | 104.00 | -- | 0.5737 | -- | -- | -1.44 | -1.44 | 0.00 | 2.54 | 0.00 | 0.00 | -- | 0.00 | -37.91 | -55.46 | -44.02 | -63.73 | -- | 66.56 | -- | -14,819.18 | 5.38 | -- | 0.006 | -- | -100.00 | -- | 7.65 | -- | -48.85 | -- |
Jbm (Healthcare) Ltd | 610.30m | 97.99m | 800.46m | 258.00 | 8.84 | 0.8535 | 5.38 | 1.31 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
Transcenta Holding Limited | 58.07m | -498.80m | 802.93m | 215.00 | -- | 0.7227 | -- | 13.83 | -1.23 | -1.23 | 0.1427 | 2.55 | 0.0281 | 2.05 | 1.49 | 270,074.80 | -24.17 | -- | -33.97 | -- | 26.74 | -- | -859.01 | -- | 1.20 | -32.87 | 0.285 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
Pak Fah Yeow International Ltd | 259.16m | 105.04m | 828.96m | 102.00 | 7.89 | 1.08 | 7.37 | 3.20 | 0.337 | 0.337 | 0.8316 | 2.46 | 0.2995 | 2.88 | 22.18 | 2,540,765.00 | 12.14 | 3.99 | 12.60 | 4.18 | 84.45 | 80.79 | 40.53 | 21.27 | 6.90 | 10.08 | 0.0062 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 907.45m | 159.81m | 845.98m | 848.00 | 5.29 | 0.530 | 6.91 | 0.9323 | 0.2853 | 0.2853 | 1.62 | 2.85 | 0.3587 | 2.18 | 2.94 | 1,070,105.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
Zhaoke Ophthalmology Ltd | 20.22m | -415.19m | 851.98m | 313.00 | -- | 0.3857 | -- | 42.14 | -0.7634 | -0.7634 | 0.0372 | 4.04 | 0.0075 | -- | 0.531 | 64,595.44 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
Fusen Pharmaceutical Co Ltd | 609.90m | -39.12m | 862.45m | 1.15k | -- | 1.42 | -- | 1.41 | -0.0524 | -0.0524 | 0.811 | 0.8103 | 0.4199 | 1.95 | 8.36 | 531,274.10 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.756 | 0.3797 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
JW (Cayman) Therapeutics Co Ltd | 187.47m | -828.14m | 974.24m | 398.00 | -- | 0.5338 | -- | 5.20 | -2.01 | -2.01 | 0.4556 | 4.40 | 0.0704 | 1.68 | 65.54 | 471,033.30 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.52m | 993.14m | 2.64k | 5.55 | 0.8784 | 3.45 | 0.4493 | 0.2072 | 0.2072 | 2.61 | 1.31 | 1.12 | 2.53 | 10.54 | 836,299.40 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
Brii Biosciences Ltd | 665.32k | -188.52m | 999.84m | 128.00 | -- | 0.2971 | -- | 1,502.80 | -0.2592 | -0.2592 | 0.0009 | 4.61 | 0.0002 | -- | -- | 5,197.81 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
Hbm Holdings Ltd | 698.51m | 177.92m | 1.08bn | 177.00 | 5.78 | 1.10 | 5.03 | 1.54 | 0.242 | 0.242 | 0.9517 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,946,381.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.18bn | 1.59k | 5.30 | 0.4947 | 2.98 | 0.7012 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
Ascletis Pharma Inc | 61.03m | -156.05m | 1.35bn | 219.00 | -- | 0.5491 | -- | 22.07 | -0.1466 | -0.1466 | 0.0568 | 2.42 | 0.022 | 2.30 | 3.86 | 278,667.70 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
Data as of May 23 2024. Currency figures normalised to Brii Biosciences Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Invesco Advisers, Inc.as of 10 Feb 2023 | 33.75m | 4.63% |
E Fund Management Co., Ltd.as of 30 Jun 2023 | 22.80m | 3.13% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 5.67m | 0.78% |
UBS Asset Management (Hong Kong) Ltd.as of 28 Mar 2024 | 4.54m | 0.62% |
SSgA Funds Management, Inc.as of 09 May 2024 | 261.00k | 0.04% |
American Century Investment Management, Inc.as of 09 May 2024 | 112.00k | 0.02% |
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2023 | 62.00k | 0.01% |
Truvalue Asset Management Co. Ltd.as of 30 Jun 2023 | 5.50k | 0.00% |
E Fund Asset Management Co. Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
Ping An Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 16 May 2024Source: FactSet Research Systems Inc.